Diagnostic Strategies in Patients Suspected of Irritable Bowel Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

149 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-02-29

Study Completion Date

2010-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether a clinical diagnosis of irritable bowel syndrome based on patient reported symptoms and a few blood tests is safe, and to determine whether a clinical diagnosis is as good for the patient and as economical for the society as a diagnosis based on exclusion of a number of organic diseases by performing a number of blood tests, fecal analyzes and a scopic examination of bowel.

The purpose of the second part of the study is to determine which intestinal parasites the patients have in their bowel and whether these parasites are the cause of the disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

"Functional Bowel Disorder. Investigation in General Practice"

NCT01153295

Irritable Bowel Syndrome

COMPLETED NA

The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)

NCT01072903

Inflammation Colon, Irritable Colonic Diseases, Functional +1 more

COMPLETED

Microbiota Community of Irritable Bowel Syndrome in Episodes and Remission Phase

NCT02566629

Irritable Bowel Syndrome

UNKNOWN

Treatment of Functional Bowel Disorders

NCT00006157

Irritable Bowel Syndrome Constipation Abdominal Pain +1 more

COMPLETED PHASE3

Developing Novel Microbiota-Targeted Therapies for Irritable Bowel Syndrome

NCT02249169

Irritable Bowel Syndrome

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irritable Bowel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Patients suspected of irritable bowel syndrome referred from GP´s, who fulfill the ROM III criteria for IBS

Exclusion diagnosis

Intervention Type OTHER

Patient fulfill ROME III criteria No Alarmsignals Blood tests: FBC,CRP, ALAT, bilirubins, bas.phosphatases, Albumine, TSH, calcium, celiac screening, lactase gene test.

3 consecutive fecal samples for worm, ovaes and parasites Sigmoidoscopy with biopsy

B

Patients suspected of irritable bowel syndrome referred from GP´s, who fulfill he ROME III criteria for IBS

Clinical diagnosis

Intervention Type OTHER

Patient fulfill ROME III criteria No Alarm signals Blood tests: FBC, CRP.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exclusion diagnosis

Patient fulfill ROME III criteria No Alarmsignals Blood tests: FBC,CRP, ALAT, bilirubins, bas.phosphatases, Albumine, TSH, calcium, celiac screening, lactase gene test.

3 consecutive fecal samples for worm, ovaes and parasites Sigmoidoscopy with biopsy

Intervention Type OTHER

Clinical diagnosis

Patient fulfill ROME III criteria No Alarm signals Blood tests: FBC, CRP.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18-50 years
* consultant in general practice for gastrointestinal symptoms, where the GP suspects irritable bowel syndrome
* full fill the ROME III criteria
* signed informed consent

Exclusion Criteria

* alarm signals
* pregnancy
* comorbid diseases, that interfere with primary endpoint
* medicine and alcohol abuse
* patient do not speak or understand danish
* investigations for irritable bowel syndrome with in the last 3 years

from november 2008: patients aged above 40 with a duration shorter than one year

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No